Clinical Trial Update: Levetiracetam Versus Oxcarbazepine as Monotherapy to Evaluate Efficacy and Safety in Subjects With Newly or Recently Diagnosed Partial Epilepsy [Phase 4]

View source ↗

Summary

A Phase 4 study compared levetiracetam with oxcarbazepine as monotherapy in patients with newly or recently diagnosed partial epilepsy, with results posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Partial Epilepsy

Drugs mentioned

• LEVETIRACETAM (levetiracetam)
• Oxcarbazepine (Oxcarbazepine)

Snippet

Sponsor: Korea UCB Co., Ltd. | Conditions: Epilepsy | Phase 4 | Status: COMPLETED | Results posted: 2015-08-20